Research Interests

Non-Invasive Treatments for Better Brain Health

Icon profile picture

I’m a research professional with expertise in neuromodulation, plasticity, neuroimaging, and data science. During my 10 years in research and teaching roles across Australia and Canada, I have worked on projects to develop and improve cutting-edge techniques that use Transcranial Magnetic Stimulation, TMS, to promote better brain health. A major goal has been to understand how the state of the network impacts the focality of stimulation, in order to make treatments more reliable and efficacious. 


I’m interested in questions like;

  • how can brain stimulation tools help us understand the neural basis for learning, memory and decision-making
  • how may we optimize neuromodulation tools in clinical settings
  • how can we achieve better targeting of brain networks using cognitive-tasks, closed-loop devices and functional-network-targeting with fMRI
  • where can TMS-biomarkers be used to predict the early signs of neurodegenerative disorders like ALS and dementia and help improve clinical care 

Optimizing Brain Research

Website IMG - Amaya and Abbey with Cut Out

We can now measure and manipulate the brain like never before. Since 1990, fMRI offered a way to observe the brain in awake humans. But with no way to activate neurons, aside from a computer task or drug, our ability to make direct causal links was limited. With TMS, we can directly activate neurons and observe the changing neurophysiology, behaviour and function. We can make causal links between brain and behaviour in awake, functioning humans.

Magnetic brain stimulation offers a safe, and painless way to stimulate the brain. Since it’s approval in the early 2000s, TMS has been used to treat symptoms of depression, Parkinson’s, and OCD. Using repeated sessions of patterned stimulation in a specified protocol, TMS can produce a lasting change in neural circuits that has a therapeutic benefit. 

The fact that TMS activates brain function without risky anesthetic or side effects means we can begin to offer patients an alternative to pharmacological or surgical treatments. 

This is huge!

In depression, TMS is replacing electro-shock-therapy. Research on deep brain stimulation in Parkinson’s has shown it can have life-changing impacts. The list of TMS applications is constantly growing, with ongoing clinical trials in schizophrenia, stroke, substance abuse disorder, ALS, and more. 

I work with an interdisciplinary team of doctors, therapists and scientists looking at ways to make these tools more reliable and use them to understand hard-to-treat diseases, like ALS. Every day I am grateful to be working at the forefront of this exciting field with such a dedicated team.

Expanding Neuromodulation Tools

A number of different techniques fall under the umbrella of neuromodulation. I specialize in transcranial magnetic stimulation (TMS) and neuroimaging (fMRI and EEG) which stimulate the cortex – the outer layer of the brain – responsible for aspects of movement, planning, attention and learning.
 
Some examples of tools being developed include:
  • transcranial magnetic stimulation (TMS) 
  • repetitive and theta-burst TMS (rTMS and cTBS)
  • transcranial direct-current stimulation (tDCS)
  • functional magnetic resonance imaging (fMRI) guided TMS
  • electroencephalography (EEG)
  • focused ultrasound stimulation (FUS)
  • deep-brain stimulation (DBS)
  • closed loop brain-machine interfaces (BCI)

It takes a team 

In my current job, I work with a team of highly-skilled doctors, clinicians and research coordinators to run ground-breaking clinical trials into ALS, a fatal neurodegenerative disease affecting the motor system. I get to supervise grad students and teach university courses on topics such as cognitive neuroscience, plasticity, attention, learning, and brain disease.
 
When I’m not in the lab, I write grants to help fund my research, speak about my work at international conferences, and collaborate to publish academic papers in high impact journals, such as Nature Reviews Neuroscience.
 

Clinical Applications of TMS in ALS

Everyday, in hospitals and clinics around the world, patients are receiving life changing brain stimulation treatment for severe depression. The origins of TMS date back to 1980, but it wasn’t until 2003 when methodical research began widespread. TMS was approved to treat depression the USA in 2008, Europe in 2012, and Australia in 2016. Treatment with TMS is only sometimes covered by provincial healthcare providers, like in some states of Canada, though is mostly self-funded. TMS is also used “off-label” to treat a range of symptoms related to stroke, Parkinson’s, addiction, OCD, neuro-degeneration and more. Clinical trials, like the ones I’m working on at Sunnybrook Hospital, continue to improve the efficacy and effectiveness of these treatments and improve patient outcomes. 
 
 

Read more about the life of a travelling scientist in my Blog, or get the juicy details straight from my academic publications.

Experience the Wonder of Science through my eyes as a Young Science Ambassador delivering school-based STEM programs in rural towns.

Run educational and leadership programs?
Book me to speak at your next event.


Lessons from my PhD…

“In hindsight, […] our implicit visual learning system was smarter than our explicit theorizing.”

– Yuhong Jiang & Joo-Huyn Song, 2005, JEP:HPP paper.